SPDR S&P Biotech ETF $XBI Shares Sold by Krilogy Financial LLC

Krilogy Financial LLC lowered its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 87.7% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 9,844 shares of the exchange traded fund’s stock after selling 69,973 shares during the period. Krilogy Financial LLC’s holdings in SPDR S&P Biotech ETF were worth $1,490,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Angeles Wealth Management LLC purchased a new position in SPDR S&P Biotech ETF in the 2nd quarter valued at $28,000. Axiom Investment Management LLC acquired a new position in SPDR S&P Biotech ETF in the 1st quarter valued at $26,000. Financial Life Planners acquired a new position in SPDR S&P Biotech ETF in the 1st quarter valued at $27,000. Morling Financial Advisors LLC acquired a new position in SPDR S&P Biotech ETF in the 2nd quarter valued at $36,000. Finally, SHP Wealth Management purchased a new position in SPDR S&P Biotech ETF during the 4th quarter worth $31,000.

SPDR S&P Biotech ETF Stock Performance

Shares of SPDR S&P Biotech ETF stock opened at $149.78 on Friday. The company has a market cap of $10.04 billion, a P/E ratio of 11.47 and a beta of 0.83. SPDR S&P Biotech ETF has a one year low of $106.30 and a one year high of $169.89. The firm has a fifty day moving average of $158.35 and a two-hundred day moving average of $146.89.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.